121
Pilot Study of SBRT and CDX-1127 in Prostate Cancer
Condition(s):Prostatic Neoplasms; Prostate CancerLast Updated:May 17, 2018Terminated
Metastatic Prostate Carcinoma in the Soft Tissue: 133 Clinical Trials, Page 13 of 14
Hide Studies Not Open or Pending
122
Radium Ra 223 With Enzalutamide Compared to Enzalutamide Alone in Men With Metastatic Castration Refractory Prostate Cancer
Condition(s):Prostate CancerLast Updated:October 30, 2020Completed
123
Gallium-68 PSMA-11 Positron Emission Tomography (PET) Imaging in Patients With Biochemical Recurrence
Condition(s):Prostate CancerLast Updated:October 8, 2020Completed
124
Safety, Pharmacokinetic and Proof-of-Concept Study of ARN-509 (Apalutamide) in Castration-Resistant Prostate Cancer (CRPC)
Condition(s):Prostate CancerLast Updated:March 2, 2021Active, not recruiting
125
A Dose Escalation and Expansion Study of TRX518 in Combination With Cyclophosphamide Plus Avelumab in Advanced Solid Tumors
Condition(s):Solid Tumors; Advanced Triple Negative Breast Cancer; Advanced Hormone Receptor Positive/Endocrine Refractory Breast Cancer; Advanced Metastatic Castration-Resistant Prostate Cancer; Advanced Platinum-Resistant Ovarian CancerLast Updated:October 27, 2020Terminated
126
Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer
Condition(s):Prostate CancerLast Updated:March 25, 2021Active, not recruiting
127
Dose-finding Study of GSK2636771 When Administered in Combination With Enzalutamide in Male Subjects With Metastatic Castration-Resistant Prostate Cancer
Condition(s):NeoplasmsLast Updated:October 22, 2020Completed
128
Erdafitinib and Abiraterone Acetate or Enzalutamide in Treating Patients With Double Negative Prostate Cancer
Condition(s):Castration-Resistant Prostate Carcinoma; Double-Negative Prostate Carcinoma; Metastatic Prostate Carcinoma; Prostate Adenocarcinoma; Stage IV Prostate Cancer AJCC v8; Stage IVA Prostate Cancer AJCC v8; Stage IVB Prostate Cancer AJCC v8Last Updated:April 13, 2021Recruiting
129
Study Comparing Orteronel Plus Prednisone in Participants With Metastatic Castration-Resistant Prostate Cancer.
Condition(s):Prostate CancerLast Updated:December 19, 2018Completed
130
Safety and Anti-Tumor Study of Oral EPI-506 for Patients With Metastatic Castration-Resistant Prostate Cancer
Condition(s):Prostatic Neoplasms; Genital Neoplasms, Male; Genital Diseases, Male; Prostatic DiseasesLast Updated:March 1, 2018Terminated